Credence Genomics launches IVF Gscan
Credence Genomics Pvt Ltd, Sri Lanka’s first and only next generation sequencing facility launched the IVF Gscan – Pre implantation genetic screening for ‘In Vitro Fertilization’ (IVF) recently.
The cutting-edge screening technology assists in IVF testing increasing success of conception.
Infertility is a serious medical problem all over the world usually caused due to various reasons including smoking, late marriages, menstrual irregularities and chronic illnesses etc. Due to the late onset of pregnancies the success of IVF has been limited till now as the ability to choose the most successful embryos for inception has not been possible till IVF Gscan. IVF Gscan increases the success rate of IVF by 20 – 30 percent as the most successful embryos are selected.
Studies globally show next generation sequencing technology used for preimplantation screening have a near 100% accuracy in identifying suitability of embryo for implantation. Obstetricians and gynecologists who integrate IVF Gscan in their IVF treatment protocol have established higher rates of success.
Credence Genomics conducted an observational study on embryos obtained from local IVF centers in Sri Lanka. Following integration of IVF Gscan in the IVF process and increase of over 52 percent in successful pregnancies was noted. Furthermore an indirect benefit is a reduction in the number of cycles for the patient and the treating physicians.
L. M. Abayasekera, Manager Lab of Credence Genomics presented the final outcome of IVF using IVF Gscan in Sri Lanka at the 51st Annual Scientific Congress of Sri Lanka College of Obstetricians & Gynecologists held on 11th& 12th of August at Sri Lanka Foundation. “Our study data shows a clear increase in the rate of successful IVF implantations by conducting pre-implantation genetic screening using IVF G-scan,” she said.
Fertility and genetic expert Dr. Padmapani Padeniya, also a senior lecturer of th Ragama Medical Faculty said, “IVF Gscan is the new frontier of testing aneuploidy in IVF technology. In fact this test provides the selective screening of embryos before being implanted hence the success rate can be enhanced. Further it will directly reduce the incidence of birth defects in Sri Lanka.”
IVF Gscan offered in Sri Lanka is done at an affordable cost and offered by leading IVF Clinics Island wide. Other products in the Gscan range also available at all leading fertility clinics include Non Invasive Gscan which is a Non-invasive screening test to evaluate the status of the baby after the 10th week of pregnancy and has over 99 percent accuracy.
Dr. Vaz Gnanam, Chairman/ceo, Credence said,” As we continue to pioneer and develop the latest accurate, tests for the region our commitment to providing the best in health care is represented in our infertility range of Gscan products. As a company we believe that this product range will add value to IVF and the general practice of obstetrics and gynecology.”